Publications

273 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from
to

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by: Date / Relevance

Rolapitant (Varuby®) for the prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults

Zorginstituut Nederland has carried out an assessment of the medicinal product rolapitant (Varuby®). The GVS report concludes ...

Report | 17-04-2018

Belimumab (Benlysta®) for the treatment of adult patients with auto-antibody-positive systemic lupus erythematosus (SLE)

Zorginstituut Nederland has carried out an assessment of the medicinal product subcutaneous belimumab (Benlysta®) and a ...

Report | 29-03-2018

Fampridine (Fampyra®) in cases of multiple sclerosis (MS)

Zorginstituut Nederland carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the outcomes of the ...

Report | 01-03-2018

Nusinersen (Spinraza®) for the treatment of 5q Spinal Muscular Atrophy

Zorginstituut Nederland carried out an assessment on the medicinal product nusinersen (Spinraza®) for the treatment of 5q Spinal ...

Report | 07-02-2018

Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia

Zorginstituut Nederland issued a package advice on the medicinal product evolocumab (Repatha®) for the treatment of ...

Report | 18-01-2018

Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis

Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL ...

Report | 04-01-2018

Zinnige Zorg room for improvement report - Chest pain (Suspected) Stable Angina Pectoris

Zorginstituut Nederland’s motto is "Taking care of good health care: no more and no less than necessary". Every citizen must be ...

Report | 17-12-2017

Zinnige Zorg room for improvement report - Appropriate use of expensive medicines in cases of metastatic renal cell carcinoma

Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...

Report | 07-12-2017

Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)

Zorginstituut Nederland has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone (Raxone®) is not ...

Report | 20-10-2017

Programme ‘Outcome Information for Shared Decision-Making’ - factsheet

Publication | 19-10-2017